Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience
β Scribed by Dr. James T. Parsons; Dr. William M. Mendenhall; Dr. Scott P. Stringer; Dr. Nicholas J. Cassisi; Dr. Rodney R. Million
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 882 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Basaloid squamous cell carcinoma (BSCC) of the head and neck is a recently described high-grade variant of squamous cell carcinoma. It is a biologically virulent neoplasm with a propensity for nodal, as well as systemic, metastases. Because of the limited number of published reports, we reviewed dat
Between March 1978 and April 1986, 21 previously untreated patients with T3 squarnous cell carcinoma of the true vocal cord received radical courses of twice-a-day radiotherapy (1 20 cGy twice daily) to total doses of 7,440-7,680 cGy. The rate of local control at the primary site was 67% after radio
## Abstract ## Objectives/Hypothesis: To discuss the role of radiotherapy (RT) in the treatment of cutaneous squamous and basal cell carcinomas of the head and neck. ## Methods: Review of the pertinent literature. ## Results: The likelihood of cure with a good cosmetic outcome is high for pati
## Abstract ## Background. To define the role of planned neck dissection after definitive radiotherapy for patients with nodeβpositive squamous cell carcinoma of the head and neck. ## Methods. Review of the pertinent literature. ## Results. Radiotherapy alone produces a relatively high likelih
A retrospective evaluation was made of 260 patients with squamous carcinoma of various head and neck sites in order to determine the relative value of continuous vs. split-course irradiation techniques. There was no obvious difference in local control or survival in early-stage cases. The continuous